| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |